Literature DB >> 20859999

Prognostic value of heparanase expression and cellular localization in oral cancer.

Yoav Leiser1, Imad Abu-El-Naaj, Edmond Sabo, Sharon Akrish, Neta Ilan, Ofer Ben-Izhak, Micha Peled, Israel Vlodavsky.   

Abstract

BACKGROUND: Metastases formation depends on the ability of tumor cells to invade basement membranes in a process involving enzymes capable of degrading extracellular matrix components.
METHODS: We examined the expression of heparanase in oral carcinomas and correlated its staining extent, intensity, and cellular localization with patients' outcome.
RESULTS: Quantitative real-time polymerase chain reaction (PCR) revealed over 4-fold increase in heparanase levels in oral carcinomas compared to adjacent normal tissue. Normal oral epithelium was found negative for heparanase, while all oral carcinomas stained positively for heparanase. Heparanase staining was associated with Ki67 staining, a measure of cell proliferation. Notably, whereas cytoplasmic localization of heparanase was associated with high-grade carcinomas, nuclear localization of the enzyme was found primarily in low-grade, well-differentiated tumors, and in all oral verrucous carcinomas.
CONCLUSION: Expression level and cellular localization of heparanase could serve as an important diagnostic marker in patients with oral cancer.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20859999      PMCID: PMC3010289          DOI: 10.1002/hed.21545

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  43 in total

1.  Heparanase induces tissue factor expression in vascular endothelial and cancer cells.

Authors:  Y Nadir; B Brenner; A Zetser; N Ilan; I Shafat; E Zcharia; O Goldshmidt; I Vlodavsky
Journal:  J Thromb Haemost       Date:  2006-09-13       Impact factor: 5.824

Review 2.  Development of heparanase inhibitors for anti-cancer therapy.

Authors:  Hua-Quan Miao; Hu Liu; Elizabeth Navarro; Paul Kussie; Zhenping Zhu
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

3.  Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival.

Authors:  Ilana Doweck; Victoria Kaplan-Cohen; Inna Naroditsky; Edmond Sabo; Neta Ilan; Israel Vlodavsky
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

4.  Heparanase expression in malignant salivary gland tumors inversely correlates with long-term survival.

Authors:  Ofer Ben-Izhak; Victoria Kaplan-Cohen; Neta Ilan; Shlomit Gan; Israel Vlodavsky; Rafael Nagler
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

5.  Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.

Authors:  Anna Zetser; Yulia Bashenko; Evgeny Edovitsky; Flonia Levy-Adam; Israel Vlodavsky; Neta Ilan
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

6.  An ELISA method for the detection and quantification of human heparanase.

Authors:  Itay Shafat; Eyal Zcharia; Benjamin Nisman; Yona Nadir; Farid Nakhoul; Israel Vlodavsky; Neta Ilan
Journal:  Biochem Biophys Res Commun       Date:  2006-01-24       Impact factor: 3.575

Review 7.  Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.

Authors:  Neta Ilan; Michael Elkin; Israel Vlodavsky
Journal:  Int J Biochem Cell Biol       Date:  2006-07-06       Impact factor: 5.085

Review 8.  Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.

Authors:  Israel Vlodavsky; Neta Ilan; Annamaria Naggi; Benito Casu
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

Review 9.  Heparanase: a target for drug discovery in cancer and inflammation.

Authors:  E A McKenzie
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

Review 10.  Mammalian heparanase: what is the message?

Authors:  Veronique Vreys; Guido David
Journal:  J Cell Mol Med       Date:  2007 May-Jun       Impact factor: 5.310

View more
  7 in total

1.  Heparanase expression correlates with poor survival in oral mucosal melanoma.

Authors:  Xin Wang; Weiwei Wen; Heming Wu; Yi Chen; Guoxin Ren; Wei Guo
Journal:  Med Oncol       Date:  2013-06-21       Impact factor: 3.064

Review 2.  Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.

Authors:  Uri Barash; Victoria Cohen-Kaplan; Ilana Dowek; Ralph D Sanderson; Neta Ilan; Israel Vlodavsky
Journal:  FEBS J       Date:  2010-08-31       Impact factor: 5.542

3.  Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase.

Authors:  Lei Yan; Keqiang Yan; Wang Kun; Lin Xu; Qian Ma; Yueqing Tang; Wei Jiao; Gangli Gu; Yidon Fan; Zhonghua Xu
Journal:  Tumour Biol       Date:  2012-10-12

4.  Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model.

Authors:  Adi Binder Gallimidi; Stuart Fischman; Brurya Revach; Raanan Bulvik; Alina Maliutina; Ariel M Rubinstein; Gabriel Nussbaum; Michael Elkin
Journal:  Oncotarget       Date:  2015-09-08

5.  Glucose-regulated protein 78 and heparanase expression in oral squamous cell carcinoma: correlations and prognostic significance.

Authors:  Fei Xia; Jin Cheng Xu; Pei Zhang; Yuan Yuan Zhang; Qian Wen Zhang; Zhen Hua Chao; Fang Wang
Journal:  World J Surg Oncol       Date:  2014-04-25       Impact factor: 2.754

Review 6.  Heparanase and the hallmarks of cancer.

Authors:  Krishnath M Jayatilleke; Mark D Hulett
Journal:  J Transl Med       Date:  2020-11-30       Impact factor: 5.531

7.  Induction of heparanase by HPV E6 oncogene in head and neck squamous cell carcinoma.

Authors:  Nir Hirshoren; Raanan Bulvik; Tzahi Neuman; Ariel M Rubinstein; Amichay Meirovitz; Michael Elkin
Journal:  J Cell Mol Med       Date:  2013-11-28       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.